Kuros Biosciences Interview at NASS 2023 | DocTech.LIVE Med-Tech Innovation Report

Описание: Welcome to Doctech.live's exclusive interview with Kuros Biosciences at NASS 2023 - the North American Spine Society's premier medical conference. Join us as we dive into the world of innovative biologics for spinal fusion with Katherine Sage, an orthopedic surgeon, and Joost DeBruijn, President Innovation & Strategy at Kuros Biosciences.
In this interview, we explore Kuros Biosciences' cutting-edge technology, including MagnetOs, a revolutionary bone graft, and Fibrin-PTH, a groundbreaking investigational drug-biologic candidate for spinal fusion. Discover how their unique surface technology and biologics are changing the game in spine surgery.

Don't miss out on this informative discussion and a glimpse into the future of spine-related pain management.

Chapters:

00:00 - Introduction to NASS 2023
00:23 - Meet the Experts
00:42 - MagnetOs: Revolutionizing Bone Grafts
01:23 - Mechanism of Action
02:02 - Surface Structure and Composition
03:05 - Versatile Applications
04:24 - Beyond Bone Growth
05:39 - Trade Shows and Global Presence
06:53 - Company History and Specialization

Join us in this illuminating interview as we unravel the future of spinal fusion and the science behind Kuros Biosciences' groundbreaking innovations. Subscribe to Doctech.live for more exclusive coverage of healthcare and medical technology advancements.

To learn more about Kuros Biosciences - https://kurosbio.com/
To learn more about DocTech.LIVE - https://doctech.live/
To learn more about Ghost Productions - https://www.ghostproductions.com/